Published :
Report ID:
Pages :
Format :
The Global Cardiac Ablation Technologies Market Size accounted for USD 4.8 Billion in 2021 and is projected to occupy a market size of USD 12.6 Billion by 2030 growing at a CAGR of 11.6% from 2022 to 2030.
Cardiac ablation technologies scars small areas of a humans heart that may be causing them heart rhythm issues. This can obstruct the passage of irregular electrical signals or rhythms through the heart.The cardiac ablation technologies market is driven by rising incidence of atrial fibrillation and technological advancement.
Cardiac Ablation Technologies Market Report Statistics
Global Cardiac Ablation Technologies Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Cardiac Ablation Technologies Market Report Coverage
Market | Cardiac Ablation Technologies Market |
Cardiac Ablation Technologies Market Size 2021 | USD 4.8 Billion |
Cardiac Ablation Technologies Market Forecast 2030 | USD 12.6 Billion |
Cardiac Ablation Technologies Market CAGR During 2022 - 2030 | 11.6% |
Cardiac Ablation Technologies Market Analysis Period | 2018 - 2030 |
Cardiac Ablation Technologies Market Base Year | 2021 |
Cardiac Ablation Technologies Market Forecast Data | 2022 - 2030 |
Segments Covered | By Technology Type, By Application, By End-User, And By Geography |
Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled | Medtronic Plc, St. Jude Medical, Inc. (Abbott), Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, CardioFocus Inc., and Biosense Webster, Inc. (Johnson & Johnson),and CONMED Corporation etc. |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Cardiac Ablation Technologies Market Growth Factors
Rising prevalence of atrial fibrillation and increase in adoption of cardiac ablation technologies for the treatment of atrial fibrillation are the driving factors boosting the growth of the cardiac ablation technologies market. Also, increase in patient preference for minimally invasive surgeries and technological advancement creates demand for cardiac ablation technologies which is bolstering the growth of the global cardiac ablation technologies market.
Cardiac Ablation Technologies Market Insights
There is huge presence of elderly population in developed countries such as the U.S, and most countries of Europe, and Japan. Developed countries are witnessing high rate of aging as compared to developing nations. This factor is contributing to the rise in improved healthcare infrastructure, favorable government norms, and technological advancements in healthcare facilities in these developed countries. Additionally, ease of access to several diagnostic services has developed in the recent years, particularly in developed countries. This, in turn, has improved the life expectancy of the population in these countries. The aged population is the target user of cardiac ablation technologies as there is higher risk of increasing cardiac diseases
Cardiac Ablation Technologies Market Segmentation
The global cardiac ablation technologies market is segmented based on technology type, application, end-user, and geography.
Cardiac Ablation Technologies Market By Technology Type
Based on technology type, the radiofrequency segment accounted for around 56% share of the global market. The radiofrequency ablation procedure is a well-known procedure that offers high safety and efficiency that leads to higher adoption of these technologies. Moreover, it is a least invasive procedure that has low risk and less pain and is easy to perform which is further contributing to the growth of global cardiac ablation technologies market.
Cardiac Ablation Technologies Market By Application
According to the cardiac ablation technologies market forecast, atrial fibrillation is expected to hold a significant market share between 2022 and 2030. As cardiac ablation technology is widely used to treat atrial fibrillation, an increase in cases is proving to be a growth generator. Revenue in the radiofrequency segment is expected to grow rapidly, accounting for more than half of global revenue.
Cardiac Ablation Technologies Market By End-User
According to the global cardiac ablation technologies industry analysis, the hospitals end-user grabbed an impressive chunk of the total end-user shares in 2021 and is expected to grow significantly over the projected period. Over the last few years, healthcare spending has skyrocketed. Furthermore, technological advancements in minimally invasive procedures combined with an increase in the number of people opting for surgeries, are driving segmental growth.
Cardiac Ablation Technologies Market Regional Outlook
North America
Europe
Asia-Pacific
Latin America
The Middle East & Africa
Cardiac Ablation Technologies Market Regional Analysis
Increase in patient preference for minimally invasive surgeries and technological advancement creates demand for cardiac ablation technologies which is one of the key factors for the growth of the cardiac ablation technologies market. North America is anticipated to hold major share of the global market, due to higher adoption of cardiac ablation technologies and increase in medical expenditure. Europe is predicted to account for a significant share of the global market during the forecast period. Increase in incidence of atrial fibrillation and other heart diseases is projected to fuel the market growth in the region. The market in Asia Pacific region is expected to grow at a rapid pace due to the rise in healthcare expenditure.
Cardiac Ablation Technologies Market Players
The major players associated with the cardiac ablation technologies market are Medtronic Plc, St. Jude Medical, Inc. (Abbott), Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, CardioFocus Inc., Biosense Webster, Inc. (Johnson & Johnson), and CONMED Corporation etc. The key players in the cardiac ablation technologies market are constantly focusing on research and development in order to expand their product portfolio and increase their customer base in developing regions. Key manufacturers invests heavily in research and development to manufacture low weighting, fuel efficient and innovative cardiac ablation technologies models. Additionally, players associated with the global cardiac ablation technologies market are focusing mainly on merger and acquisition and developing strategic partnerships with other players in order to expand their product portfolio and to increase the market share.
The market size of cardiac ablation technologies market in 2021 was accounted to be USD 4.8 Billion.
The projected CAGR of cardiac ablation technologies market during the analysis period of 2022 to 2030 is 11.6%.
The prominent players of the global cardiac ablation technologies market include Medtronic Plc, St. Jude Medical, Inc. (Abbott), Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, CardioFocus Inc., Biosense Webster, Inc. (Johnson & Johnson), and CONMED Corporation.
North America held the dominating cardiac ablation technologies during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for cardiac ablation technologies during the analysis period of 2022 to 2030.
Growing prevalence of CVDs such as cardiac arrhythmias, increasing awareness for cardiac ablation procedures over conventional procedures, and rising elderly population across the world drives the growth of global cardiac ablation technologies market.
Based on technology type, radiofrequency segment is expected to hold the maximum share of the cardiac ablation technologies market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date